key: cord-0744744-d5g8osxu
authors: Zhao, Zhenzhen; Yang, Chao; Li, Changchun
title: Strategies for patient with cancer during COVID‐19 pandemic
date: 2020-04-20
journal: Asia Pac J Clin Oncol
DOI: 10.1111/ajco.13363
sha: 6d8a7096186d1629b970cca5c6aba40f58f7ed6c
doc_id: 744744
cord_uid: d5g8osxu

nan

Wenhua Liang and his colleagues 1 first reported a nationwide analysis of cancer patients with SARS-CoV-2 infection in China. They found COVID-19 cases with a history of cancer was higher than the incidence of cancer in the overall Chinese population, suggesting that cancer patients were more susceptible to infenction, and were observed to have a higher risk of severe events. They suggested an intentional postponing of adjuvant chemotherapy or elective surgery for stable cancer in endemic areas. However, the specific clinical strategies for patients with cancer remain unclear; it is urgent to put forward the strategies of cancer management during the pandemic .

For surgery consideration, no matter benign or malignant tumor, if rapid progress, severe organ function impaired or life-threatening situation exists, emergency operation should be conducted. The need for and type of operation should be comprehensively assessed and arranged according to the local epidemic and hospital situation. Where appropriate, neoadjuvant chemotherapy is recommended after the initial diagnosis, and upfront radical surgery is not recommended during the pandemic period. Blood shortage may exist during the pandemic; availability of blood products must be ensured before operation.

Chemotherapy in a local hospital is recommended in order to reduce population migration. High-dose chemotherapy and regimens with severe myelotoxicity should be avoided, of G-CSF should be given. Reducing the dose of chemotherapy to ensure the safety of patients is an option if necessary. Oral chemotherapy drugs to achieve home-based treatment is recommended, especially for palliative treatment.

Radiotherapy may aggravate myelosuppression and increases the risk of COVID-19 infection due to greater exposure. However, there are many options for radiotherapy timing in the comprehensive treatment plan, so it is recommended to postpone the radiotherapy plan if it is not necessary during the pandemic. Where appropriate, single fraction or short courses of radiation are advised.

Ward and outpatient management is crucial for the safety of patients with cancer. Triple pre-examination consisted of "entering hospital", "general area", and "cancer clinic area" can be adopted. It is recommended to establish and follow a uniform hospital admission process for cancer patients (figure 1).

All infection prevention and control measures for COVID-19 must be strictly implemented 2,3 . The number of healthcare workers in the ward should be limited.

Risk-based protection measures should be taken to minimize nosocomial infection according to the exposure risk of staff in different positions. We recommend to set up three areas (clean area, potentially contaminated area and contaminated area) and two people movement pathways (medical staff channel and patient's channel) as well as isolation rooms in the ward. Adequate disinfection should meet meet the corresponding guidance requirements. 

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

National Health Commission of PRC. Technique Guidelines of Preventing and Controlling Novel Coronavirus Infection within Healthcare Institutions

National Health Commission of PRC. Diagnostic and Therapeutic Protocols for Novel Coronavirus-Infected Pneumonia